XML 40 R45.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Details 3) (USD $)
12 Months Ended 1 Months Ended 0 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Feb. 28, 2011
Initial public offering
Dec. 28, 2012
Public Offering of Common Stock
Dec. 31, 2012
Stock option
Dec. 31, 2011
Stock option
Dec. 31, 2010
Stock option
Dec. 31, 2011
Stock option
Minimum
Dec. 31, 2010
Stock option
Minimum
Dec. 31, 2011
Stock option
Maximum
Dec. 31, 2010
Stock option
Maximum
Jul. 31, 2007
Stock option
Employees
Dec. 31, 2012
Stock option
Employees
Dec. 31, 2011
Stock option
Employees
Dec. 31, 2010
Stock option
Employees
Jul. 31, 2007
Stock option
Non-employees
Dec. 31, 2012
Stock option
Non-employees
Dec. 31, 2011
Stock option
Non-employees
Dec. 31, 2010
Stock option
Non-employees
Dec. 31, 2012
Restricted stock awards
Dec. 31, 2011
Restricted stock awards
Stock-Based Compensation                                            
Cumulative grant date fair value                           $ 347,000 $ 244,000 $ 118,000            
Intrinsic value of options exercised                           0 58,000 0            
Proceeds received for options exercised 1,000 88,000                       500 87,500 0            
Compensation expense related to unvested employee stock options not yet recognized           577,000 944,000 608,000                            
Weighted-average period of recognition           2 years 3 months 11 days 2 years 8 months 19 days 1 year 10 months 17 days                            
Vesting period                         4 years       3 years       4 years  
Stock-based compensation $ 588,000 $ 492,000 $ 625,000                             $ 20,000 $ 30,000 $ 388,000 $ 255,000 $ 159,000
Assumptions used                                            
Risk free interest rate, minimum (as a percent)             1.24% 2.45%                            
Risk free interest rate, maximum (as a percent)             2.63% 2.82%                            
Risk free interest rate (as a percent)           0.92%                                
Dividend yield (as a percent)           0.00% 0.00% 0.00%                            
Expected volatility (as a percent)           57.00% 53.00% 50.00%                            
Expected term           6 years 3 months     5 years 9 months 5 years 9 months 6 years 3 months 6 years 3 months                    
Weighted average grant date fair value (in dollars per share)           $ 0.54 $ 1.76 $ 3.56                            
Number of Shares                                            
Awards outstanding at the beginning of the period (in shares)                                         135,000  
Granted (in shares)                                           135,000
Vested (in shares)                                         (67,500)  
Awards outstanding at the end of the period (in shares)                                         67,500 135,000
Weighted Average Fair Value                                            
Awards outstanding at the beginning of the period (in dollars per share)                                         $ 5.89  
Granted (in dollars per share)                                           $ 5.89
Vested (in dollars per share)                                         $ 3.79  
Awards outstanding at the end of the period (in dollars per share)                                         $ 8.00 $ 5.89
Common Stock Purchase Options issued to underwriters                                            
Issuance of option to purchase common stock (in shares)       103,125 500,000                                  
Exercise price of options issued to underwriters (in dollars per share)       $ 10.00 $ 0.8125                                  
Exercise price of options as a percentage of purchase price of shares sold in initial public offering       125.00% 125.00%                                  
Term of options issued to underwriters       5 years 5 years                                  
Term after effective date of IPO after which stock options to underwriters become exercisable       1 year 1 year